OBSTRUCTIVE VS RESTRICTIVE LUNG DISEASE
Respiratory pathophysiology is often best understood by recognising two broad patterns of lung dysfunction: obstructive and restrictive disease. These patterns describe how airflow and lung volumes are impaired, rather than identifying a single diagnosis. Many respiratory conditions fall predominantly into one category, and understanding the distinction allows clinicians to interpret symptoms, lung function tests and imaging more accurately.
Obstructive lung disease is characterised by difficulty getting air out of the lungs, while restrictive lung disease is defined by difficulty getting air into the lungs. Although both patterns impair gas exchange and cause breathlessness, the underlying mechanisms, physiological consequences and clinical implications differ significantly.
What You Need to Know
Obstructive and restrictive lung diseases describe two distinct patterns of abnormal breathing mechanics. In obstructive lung disease, the primary difficulty is moving air out of the lungs. Airflow is limited because airway resistance is increased, most commonly due to airway narrowing, inflammation, mucus accumulation, or loss of elastic recoil that normally keeps airways open during expiration. This causes expiration to become prolonged and incomplete, allowing air to remain trapped in the lungs and leading to progressive hyperinflation.
At a broad level, these mechanical differences can be summarised as follows:
In obstructive disease, expiration is impaired due to increased airway resistance, leading to air trapping and hyperinflation
In restrictive disease, inspiration is impaired because lung or chest wall expansion is limited, leading to reduced lung volumes
In restrictive lung disease, the problem lies in reduced lung expansion during inspiration rather than difficulty with airflow. The lungs, chest wall, or respiratory muscles limit how much air can be drawn in, resulting in reduced lung volumes. This restriction may arise from intrinsic lung pathology, such as interstitial fibrosis, where stiffened lung tissue resists expansion, or from extrinsic factors such as neuromuscular disease, chest wall disorders, or obesity. In these conditions, airflow through the airways may remain relatively preserved, but the total amount of air the lungs can hold is reduced.
Beyond the Basics
Obstructive lung disease: impaired expiration and air trapping
The defining feature of obstructive lung disease is increased resistance to airflow, most evident during expiration. In healthy lungs, elastic recoil of the alveoli helps maintain airway patency as air is exhaled. In obstructive disease, this recoil is reduced, or the airway walls are narrowed by inflammation, smooth muscle contraction, or mucus, leading to premature airway collapse before expiration is complete.
As expiration becomes inefficient, air remains trapped within the alveoli at the end of each breath. This increases residual volume and functional residual capacity, meaning more air is left in the lungs even at rest. Progressive air trapping leads to lung hyperinflation, which flattens the diaphragm and shortens its muscle fibres, reducing mechanical efficiency and increasing the effort required to breathe.
Ventilation–perfusion mismatch commonly develops because poorly ventilated alveoli continue to receive pulmonary blood flow. This mismatch contributes to hypoxaemia and, in more advanced disease, carbon dioxide retention due to inadequate alveolar ventilation. Patients often instinctively prolong expiration or use pursed-lip breathing, which increases airway pressure during exhalation and helps delay airway collapse.
Restrictive lung disease: impaired expansion and reduced lung volumes
Restrictive lung disease is characterised by decreased lung compliance, meaning the lungs are stiff and resist expansion. When the lung tissue itself is affected, as in pulmonary fibrosis, scarring of the interstitium (the connective tissue supporting the alveoli) limits alveolar expansion during inspiration. This directly reduces lung volumes and increases the work required to inhale.
Restriction can also arise from external factors that limit chest wall movement or diaphragmatic excursion. Neuromuscular disease weakens the muscles responsible for inspiration, while chest wall disorders and obesity mechanically restrict thoracic expansion. In these situations, the lung tissue may be structurally normal, but the lungs cannot fully expand within the chest.
Because inspiratory capacity is reduced, total lung capacity, vital capacity, and inspiratory reserve volume are all decreased. Unlike obstructive disease, airflow rates may remain relatively preserved, but the overall volume of air moved with each breath is diminished. Patients typically adopt rapid, shallow breathing as a compensatory strategy to maintain minute ventilation.
Spirometry patterns and functional differences
Pulmonary function testing highlights the mechanical differences between obstructive and restrictive disease. In obstructive disease, forced expiratory volume in one second (FEV₁) is markedly reduced due to airflow limitation, while forced vital capacity (FVC) may be normal or only mildly reduced. This disproportionate reduction results in a decreased FEV₁/FVC ratio.
In restrictive disease, both FEV₁ and FVC are reduced in proportion because lung volumes are globally decreased. As a result, the FEV₁/FVC ratio is normal or increased. Confirmation of true restriction requires lung volume measurement demonstrating reduced total lung capacity, as spirometry alone cannot distinguish restriction from severe air trapping.
Progression and systemic consequences
Both obstructive and restrictive lung diseases increase the work of breathing and place sustained demand on respiratory muscles. Over time, this increased workload can lead to respiratory muscle fatigue and, in advanced cases, ventilatory failure.
Chronic hypoxaemia triggers pulmonary vasoconstriction, increasing pulmonary vascular resistance and placing strain on the right side of the heart. This can progress to pulmonary hypertension and right-sided heart failure. Although the initiating mechanisms differ between obstructive and restrictive disease, prolonged impairment of ventilation and gas exchange in both patterns can lead to significant systemic consequences beyond the lungs.
Clinical Connections
Patients with obstructive lung disease commonly present with wheeze, prolonged expiration, productive cough, and episodic breathlessness. Symptom patterns vary by condition, with asthma often showing intermittent, reversible airflow limitation and periods of relative normality, while chronic obstructive pulmonary disease is characterised by progressive, persistent symptoms related to fixed airway obstruction and loss of elastic recoil. On examination, prolonged expiratory phase and use of accessory muscles may be observed, reflecting increased effort to overcome airway resistance and empty the lungs.
Restrictive lung disease more often presents with exertional dyspnoea, reduced exercise tolerance, and a dry, non-productive cough. Chest expansion may be visibly reduced, and auscultation can reveal fine inspiratory crackles, particularly in interstitial lung disease, caused by the opening of stiff alveoli during inspiration. Breathlessness in restrictive disease is driven by reduced lung volumes and impaired oxygen diffusion rather than airflow obstruction, which explains why wheeze is typically absent.
These contrasting mechanisms influence both investigation and ongoing monitoring.
In clinical practice, differentiation is supported by:
Spirometry patterns showing reduced FEV₁/FVC ratio in obstructive disease versus preserved or increased ratio in restrictive disease
Oxygenation trends, with exertional desaturation occurring early in many restrictive disorders
Imaging findings, where hyperinflation supports obstructive disease and interstitial changes suggest restriction
Clear distinction between obstructive and restrictive patterns allows targeted investigation, appropriate treatment selection, and accurate explanation of symptoms and disease progression for patients across a range of respiratory conditions.
Concept Check
Why does obstructive lung disease primarily impair expiration rather than inspiration?
How does air trapping contribute to breathlessness in obstructive conditions?
What mechanisms reduce lung compliance in restrictive lung disease?
Why is the FEV₁/FVC ratio reduced in obstructive disease but normal in restrictive disease?
How can both patterns ultimately lead to pulmonary hypertension?